Trending with Impact: BRAF Inhibitor vs. Encorafenib in Colorectal Cancer
This in vitro study represents the first individual comparison of a tier one drug, encorafenib,... read more
October 1, 2020
Tagged: cancer
New Synergistic Method of Treatment for Select Lymphomas
A team of scientists from Columbia University Medical Center has formulated a new, synergistic method... read more
September 29, 2020